Vincerx Pharma Beheer
Beheer criteriumcontroles 4/4
Vincerx Pharma's CEO is Ahmed Hamdy, appointed in Dec 2020, has a tenure of 3.92 years. total yearly compensation is $734.95K, comprised of 65.2% salary and 34.8% bonuses, including company stock and options. directly owns 5.55% of the company’s shares, worth $625.70K. The average tenure of the management team and the board of directors is 3.5 years and 3.8 years respectively.
Belangrijke informatie
Ahmed Hamdy
Algemeen directeur
US$735.0k
Totale compensatie
| Percentage CEO-salaris | 65.2% |
| Dienstverband CEO | 3.9yrs |
| Eigendom CEO | 5.6% |
| Management gemiddelde ambtstermijn | 3.5yrs |
| Gemiddelde ambtstermijn bestuur | 3.8yrs |
Recente managementupdates
Recent updates
Here's Why Vincerx Pharma (NASDAQ:VINC) Must Use Its Cash Wisely
Aug 21
Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Jul 18Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Mar 30Can Vincerx Pharma (NASDAQ:VINC) Afford To Invest In Growth?
Sep 22Is Vincerx Pharma (NASDAQ:VINC) In A Good Position To Invest In Growth?
Jun 24Vincerx Pharma doses first patient in early-stage VIP152 cancer study
Jun 03Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -US$28m |
| Mar 31 2024 | n/a | n/a | -US$38m |
| Dec 31 2023 | US$735k | US$479k | -US$40m |
| Sep 30 2023 | n/a | n/a | -US$47m |
| Jun 30 2023 | n/a | n/a | -US$54m |
| Mar 31 2023 | n/a | n/a | -US$61m |
| Dec 31 2022 | US$1m | US$460k | -US$63m |
| Sep 30 2022 | n/a | n/a | -US$58m |
| Jun 30 2022 | n/a | n/a | -US$66m |
| Mar 31 2022 | n/a | n/a | -US$49m |
| Dec 31 2021 | US$615k | US$460k | -US$39m |
| Sep 30 2021 | n/a | n/a | -US$49m |
| Jun 30 2021 | n/a | n/a | -US$25m |
| Mar 31 2021 | n/a | n/a | -US$23m |
| Dec 31 2020 | US$622k | US$15k | -US$17m |
Compensatie versus markt: Ahmed's total compensation ($USD734.95K) is about average for companies of similar size in the US market ($USD655.65K).
Compensatie versus inkomsten: Ahmed's compensation has been consistent with company performance over the past year.
CEO
Ahmed Hamdy (59 yo)
3.9yrs
Tenure
US$734,953
Compensatie
Dr. Ahmed M. Hamdy, M.D., is Co-Founder of Vincerx Pharma, Inc. (formerly known as Vincera Pharma, Inc.) and has been its Chief Executive Officer and Chairman of the Board since December 2020. He served as...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 3.9yrs | US$734.95k | 5.55% $ 625.7k | |
| Co-Founder | 3.9yrs | US$668.96k | 0.28% $ 31.5k | |
| Chief Financial Officer | 3.9yrs | US$565.67k | 0.11% $ 12.1k | |
| Founder | 3.7yrs | US$3.16m | geen gegevens | |
| Founder & Chairman of Scientific Advisory Board | no data | geen gegevens | 5.24% $ 590.6k | |
| Chief Scientific Officer | 3.7yrs | geen gegevens | geen gegevens | |
| Vice President of Investor Relations & Corporate Communications and Chief of Staff | 1.3yrs | geen gegevens | geen gegevens | |
| Vice President of Quality Operations & Compliance | 1.8yrs | geen gegevens | geen gegevens | |
| Senior Director of People & Culture and Head of Human Resource | 3.3yrs | geen gegevens | geen gegevens | |
| Executive Chief Development Officer | 3.5yrs | geen gegevens | geen gegevens | |
| Chief Business Officer | 1.4yrs | geen gegevens | geen gegevens | |
| VP of Biologics Development and Manufacturing and Sr. VP of Chemistry & Manufacturing | 1.4yrs | geen gegevens | geen gegevens |
3.5yrs
Gemiddelde duur
59yo
Gemiddelde leeftijd
Ervaren management: VINC's management team is considered experienced (3.5 years average tenure).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Co-Founder | 3.9yrs | US$734.95k | 5.55% $ 625.7k | |
| Co-Founder | 3.9yrs | US$668.96k | 0.28% $ 31.5k | |
| Founder & Chairman of Scientific Advisory Board | 3.6yrs | geen gegevens | 5.24% $ 590.6k | |
| Independent Director | 3.9yrs | US$69.14k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$47.89k | 0.18% $ 20.0k | |
| Member of Scientific Advisory Board | 3.6yrs | geen gegevens | geen gegevens | |
| Independent Director | 3.9yrs | US$52.89k | 0.062% $ 7.0k | |
| Independent Director | 3.5yrs | US$47.89k | 0% $ 0 | |
| Member of Scientific Advisory Board | 3.6yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 3.6yrs | geen gegevens | geen gegevens | |
| Member of Scientific Advisory Board | 3.6yrs | geen gegevens | geen gegevens | |
| Independent Director | 3.9yrs | US$47.89k | 0.0026% $ 291.9 |
3.8yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren bestuur: VINC's board of directors are considered experienced (3.8 years average tenure).